Literature DB >> 23152136

Proteomic snapshot of breast cancer cell cycle: G1/S transition point.

Milagros J Tenga1, Iulia M Lazar.   

Abstract

The biological processes that unfold during the G1-phase of the cell cycle are dependent on extracellular mitogenic factors that signal the cell to enter a state of quiescence, or commit to a cell-cycle round by passing the restriction point (R-point) and enter the S-phase. Unlike normal cells, cancer cells evolved the ability to evade the R-point and continue through the cell cycle even in the presence of extensive DNA damage or absence of mitogenic signals. The purpose of this study was to perform a quantitative proteomic evaluation of the biological processes that are responsible for driving MCF-7 breast cancer cells into division even when molecular checkpoints such as the G1/S R-point are in place. Nuclear and cytoplasmic fractions of the G1 and S cell-cycle phases were analyzed by LC-MS/MS to result in the confident identification of more than 2700 proteins. Statistical evaluation of the normalized data resulted in the selection of proteins that displayed twofold or more change in spectral counts in each cell state. Pathway mapping, functional annotation clustering, and protein interaction network analysis revealed that the top-scoring clusters that could play a role in overriding the G1/S transition point included DNA damage response, chromatin remodeling, transcription/translation regulation, and signaling proteins.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23152136      PMCID: PMC4123745          DOI: 10.1002/pmic.201200188

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  72 in total

Review 1.  Mitochondrial chaperones in cancer: from molecular biology to clinical diagnostics.

Authors:  Anna M Czarnecka; Claudia Campanella; Giovanni Zummo; Francesco Cappello
Journal:  Cancer Biol Ther       Date:  2006-07-01       Impact factor: 4.742

2.  ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction.

Authors:  Guiqing Huang; Sheryl Krig; David Kowbel; Hongmei Xu; Bill Hyun; Stas Volik; Burt Feuerstein; Gordon B Mills; David Stokoe; Paul Yaswen; Colin Collins
Journal:  Hum Mol Genet       Date:  2005-10-03       Impact factor: 6.150

3.  Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein.

Authors:  Abdelmajid Sabile; Andrea Michael Meyer; Christiane Wirbelauer; Daniel Hess; Ulrike Kogel; Martin Scheffner; Wilhelm Krek
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

Review 4.  Role of MBD2 in gene regulation and tumorigenesis.

Authors:  J Berger; A Bird
Journal:  Biochem Soc Trans       Date:  2005-12       Impact factor: 5.407

5.  Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation.

Authors:  Hetal A Sarvaiya; Jung H Yoon; Iulia M Lazar
Journal:  Rapid Commun Mass Spectrom       Date:  2006       Impact factor: 2.419

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Nuclear protein NP60 regulates p38 MAPK activity.

Authors:  Jing Fu; Ziqiang Yang; Jinxue Wei; Jiahuai Han; Jun Gu
Journal:  J Cell Sci       Date:  2005-12-13       Impact factor: 5.285

Review 8.  C-terminal binding proteins: emerging roles in cell survival and tumorigenesis.

Authors:  L M Bergman; J P Blaydes
Journal:  Apoptosis       Date:  2006-06       Impact factor: 4.677

9.  Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis.

Authors:  Peter C Scacheri; Sean Davis; Duncan T Odom; Gregory E Crawford; Stacie Perkins; Mohamad J Halawi; Sunita K Agarwal; Stephen J Marx; Allen M Spiegel; Paul S Meltzer; Francis S Collins
Journal:  PLoS Genet       Date:  2006-04-07       Impact factor: 5.917

Review 10.  The Prohibitins: emerging roles in diverse functions.

Authors:  Suresh Mishra; Leigh C Murphy; Liam J Murphy
Journal:  J Cell Mol Med       Date:  2006 Apr-Jun       Impact factor: 5.310

View more
  11 in total

1.  Proteolytic Digestion and TiO2 Phosphopeptide Enrichment Microreactor for Fast MS Identification of Proteins.

Authors:  Jingren Deng; Iulia M Lazar
Journal:  J Am Soc Mass Spectrom       Date:  2016-02-16       Impact factor: 3.109

2.  Identification of breast cancer prognostic modules based on weighted protein-protein interaction networks.

Authors:  Wan Li; Xue Bai; Erqiang Hu; Hao Huang; Yiran Li; Yuehan He; Junjie Lv; Lina Chen; Weiming He
Journal:  Oncol Lett       Date:  2017-03-27       Impact factor: 2.967

3.  Systems-Level Proteomics Evaluation of Microglia Response to Tumor-Supportive Anti-Inflammatory Cytokines.

Authors:  Shreya Ahuja; Iulia M Lazar
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 8.786

4.  Proteomic study reveals a functional network of cancer markers in the G1-Stage of the breast cancer cell cycle.

Authors:  Milagros J Tenga; Iulia M Lazar
Journal:  BMC Cancer       Date:  2014-09-24       Impact factor: 4.430

5.  Cell Cycle Model System for Advancing Cancer Biomarker Research.

Authors:  Iulia M Lazar; Ina Hoeschele; Juliana de Morais; Milagros J Tenga
Journal:  Sci Rep       Date:  2017-12-21       Impact factor: 4.379

6.  The Targeted Antitumor Effects of C- PC/CMC-CD59sp Nanoparticles on HeLa Cells in Vitro and in Vivo.

Authors:  Yujuan Wang; Liangqian Jiang; Qifeng Yin; Huihui Liu; Guoxiang Liu; Guoteng Zhu; Bing Li
Journal:  J Cancer       Date:  2017-08-25       Impact factor: 4.207

7.  Proteogenomic Analysis of Protein Sequence Alterations in Breast Cancer Cells.

Authors:  Iulia M Lazar; Arba Karcini; Shreya Ahuja; Carly Estrada-Palma
Journal:  Sci Rep       Date:  2019-07-17       Impact factor: 4.379

8.  Signs of carcinogenicity induced by parathion, malathion, and estrogen in human breast epithelial cells (Review).

Authors:  Gloria M Calaf; Tammy C Bleak; Debasish Roy
Journal:  Oncol Rep       Date:  2021-03-02       Impact factor: 3.906

9.  Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer.

Authors:  Gangga Anuraga; Wei-Jan Wang; Nam Nhut Phan; Nu Thuy An Ton; Hoang Dang Khoa Ta; Fidelia Berenice Prayugo; Do Thi Minh Xuan; Su-Chi Ku; Yung-Fu Wu; Vivin Andriani; Muhammad Athoillah; Kuen-Haur Lee; Chih-Yang Wang
Journal:  J Pers Med       Date:  2021-10-26

10.  Recurrent chimeric fusion RNAs in non-cancer tissues and cells.

Authors:  Mihaela Babiceanu; Fujun Qin; Zhongqiu Xie; Yuemeng Jia; Kevin Lopez; Nick Janus; Loryn Facemire; Shailesh Kumar; Yuwei Pang; Yanjun Qi; Iulia M Lazar; Hui Li
Journal:  Nucleic Acids Res       Date:  2016-02-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.